Clinicopathologic assessment and imaging of tauopathies in neurodegenerative dementias

Alzheimer's Research and Therapy

Volumn 6, Issue 1, 2014, Pages

  Murray, Melissa E ^a   Kouri, Naomi ^a   Lin, Wen Lang ^a   Jack, Clifford R ^b   Dickson, Dennis W ^a   Vemuri, Prashanthi ^b  

^a MAYO GRADUATE SCHOOL   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE; TAU PROTEIN;

ALZHEIMER DISEASE; CORTICOBASAL DEGENERATION; HUMAN; NERVE CELL LESION; NEUROIMAGING; NIEMANN PICK DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; REVIEW; TAUOPATHY;

EID: 84891783062     PISSN: None     EISSN: 17589193     Source Type: Journal    
DOI: 10.1186/alzrt231     Document Type: Review

References (137)

1. Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration. ML Billingsley, RL Kincaid, Biochem J 1997 323 577 591 9169588
2. Cortical and subcortical argyrophilic grains characterize a disease associated with adult onset dementia. H Braak, E Braak, Neuropathol Appl Neurobiol 1989 15 13 26 10.1111/j.1365-2990.1989.tb01146.x 2471109
3. Parkinsonism-dementia complex of Guam. JC Steele, Mov Disord 2005 20 99 S107 10.1002/mds.20547 16092098
4. White matter tauopathy with globular glial inclusions: a distinct sporadic frontotemporal lobar degeneration. GG Kovacs, K Majtenyi, S Spina, JR Murrell, E Gelpi, R Hoftberger, G Fraser, RA Crowther, M Goedert, H Budka, B Ghetti, J Neuropathol Exp Neurol 2008 67 963 975 10.1097/NEN.0b013e318187a80f 18800011
5. Frontal lobe dementia with novel tauopathy: sporadic multiple system tauopathy with dementia. EH Bigio, AM Lipton, SH Yen, ML Hutton, M Baker, P Nacharaju, CL White 3rd, P Davies, W Lin, DW Dickson, J Neuropathol Exp Neurol 2001 60 328 341 11305868
6. Structural characterization of the core of the paired helical filament of Alzheimer disease. CM Wischik, M Novak, PC Edwards, A Klug, W Tichelaar, RA Crowther, Proc Natl Acad Sci USA 1988 85 4884 4888 10.1073/pnas.85.13.4884 2455299
7. Unusual paired helical filaments in progressive supranuclear palsy. S Takauchi, T Mizuhara, K Miyoshi, Acta Neuropathol 1983 59 225 228 10.1007/BF00703207 6682611
8. Ultrastructural instability of paired helical filaments from corticobasal degeneration as examined by scanning transmission electron microscopy. H Ksiezak-Reding, E Tracz, LS Yang, DW Dickson, M Simon, JS Wall, Am J Pathol 1996 149 639 651 8702002
9. Presence of two different fibril subtypes in the Pick body: an immunoelectron microscopic study. S Kato, H Nakamura, Acta Neuropathol 1990 81 125 129 10.1007/BF00334500 2082652
10. Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. M Hutton, CL Lendon, P Rizzu, M Baker, S Froelich, H Houlden, S Pickering-Brown, S Chakraverty, A Isaacs, A Grover, J Hackett, J Adamson, S Lincoln, D Dickson, P Davies, RC Petersen, M Stevens, E de Graaff, E Wauters, J van Baren, M Hillebrand, M Joosse, JM Kwon, P Nowotny, LK Che, J Norton, JC Morris, LA Reed, J Trojanowski, H Basun, et al. Nature 1998 393 702 705 10.1038/31508 9641683
11. Tau is a candidate gene for chromosome 17 frontotemporal dementia. P Poorkaj, TD Bird, E Wijsman, E Nemens, RM Garruto, L Anderson, A Andreadis, WC Wiederholt, M Raskind, GD Schellenberg, Ann Neurol 1998 43 815 825 10.1002/ana.410430617 9629852
12. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. MG Spillantini, JR Murrell, M Goedert, MR Farlow, A Klug, B Ghetti, Proc Natl Acad Sci U S A 1998 95 7737 7741 10.1073/pnas.95.13.7737 9636220
13. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. M Baker, IR Mackenzie, SM Pickering-Brown, J Gass, R Rademakers, C Lindholm, J Snowden, J Adamson, AD Sadovnick, S Rollinson, A Cannon, E Dwosh, D Neary, S Melquist, A Richardson, D Dickson, Z Berger, J Eriksen, T Robinson, C Zehr, CA Dickey, R Crook, E McGowan, D Mann, B Boeve, H Feldman, M Hutton, Nature 2006 442 916 919 10.1038/nature05016 16862116
14. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. M Cruts, I Gijselinck, J van der Zee, S Engelborghs, H Wils, D Pirici, R Rademakers, R Vandenberghe, B Dermaut, JJ Martin, C van Duijn, K Peeters, R Sciot, P Santens, T De Pooter, M Mattheijssens, M Van den Broeck, I Cuijt, K Vennekens, PP De Deyn, S Kumar-Singh, C Van Broeckhoven, Nature 2006 442 920 924 10.1038/nature05017 16862115
15. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-Linked FTD and ALS. M Dejesus-Hernandez, IR Mackenzie, BF Boeve, AL Boxer, M Baker, NJ Rutherford, AM Nicholson, NA Finch, H Flynn, J Adamson, N Kouri, A Wojtas, P Sengdy, GY Hsiung, A Karydas, WW Seeley, KA Josephs, G Coppola, DH Geschwind, ZK Wszolek, H Feldman, DS Knopman, RC Petersen, BL Miller, DW Dickson, KB Boylan, NR Graff-Radford, R Rademakers, Neuron 2011 72 245 256 10.1016/j.neuron.2011.09.011 21944778
16. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. AE Renton, E Majounie, A Waite, J Simon-Sanchez, S Rollinson, JR Gibbs, JC Schymick, H Laaksovirta, JC van Swieten, L Myllykangas, H Kalimo, A Paetau, Y Abramzon, AM Remes, A Kaganovich, SW Scholz, J Duckworth, J Ding, DW Harmer, DG Hernandez, JO Johnson, K Mok, M Ryten, D Trabzuni, RJ Guerreiro, RW Orrell, J Neal, A Murray, J Pearson, IE Jansen, et al. Neuron 2011 72 257 268 10.1016/j.neuron.2011.09.010 21944779
17. The genetics and neuropathology of Alzheimer's disease. GD Schellenberg, TJ Montine, Acta Neuropathol 2012 124 305 323 10.1007/s00401-012-0996-2 22618995
18. Advances in understanding the molecular basis of frontotemporal dementia. R Rademakers, M Neumann, IR Mackenzie, Nat Rev Neurol 2012 8 423 434 22732773
19. Ubiquitination and abnormal phosphorylation of paired helical filaments in Alzheimer's disease. K Iqbal, I Grundke-Iqbal, Mol Neurobiol 1991 5 399 410 10.1007/BF02935561 1726645
20. Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain. M Goedert, MG Spillantini, MC Potier, J Ulrich, RA Crowther, EMBO J 1989 8 393 399 2498079
21. Structure and novel exons of the human tau gene. A Andreadis, WM Brown, KS Kosik, Biochemistry 1992 31 10626 10633 10.1021/bi00158a027 1420178
22. A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis. SG Greenberg, P Davies, Proc Natl Acad Sci USA 1990 87 5827 5831 10.1073/pnas.87.15.5827 2116006
23. Abnormal Tau proteins in progressive supranuclear palsy. Similarities and differences with the neurofibrillary degeneration of the Alzheimer type. S Flament, A Delacourte, M Verny, JJ Hauw, F Javoy-Agid, Acta Neuropathol 1991 81 591 596 10.1007/BF00296367 1831952
24. Ultrastructure and biochemical composition of paired helical filaments in corticobasal degeneration. H Ksiezak-Reding, K Morgan, LA Mattiace, P Davies, WK Liu, SH Yen, K Weidenheim, DW Dickson, Am J Pathol 1994 145 1496 1508 7992852
25. Specific pathological Tau protein variants characterize Pick's disease. A Delacourte, Y Robitaille, N Sergeant, L Buee, PR Hof, A Wattez, A Laroche-Cholette, J Mathieu, P Chagnon, D Gauvreau, J Neuropathol Exp Neurol 1996 55 159 168 10.1097/00005072-199602000-00004 8786374
26. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. NJ Cairns, EH Bigio, IR Mackenzie, M Neumann, VM Lee, KJ Hatanpaa, CL White 3rd, JA Schneider, LT Grinberg, G Halliday, C Duyckaerts, JS Lowe, IE Holm, M Tolnay, K Okamoto, H Yokoo, S Murayama, J Woulfe, DG Munoz, DW Dickson, PG Ince, JQ Trojanowski, DM Mann, Acta Neuropathol 2007 114 5 22 10.1007/s00401-007-0237-2 17579875
27. Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. BT Hyman, JQ Trojanowski, J Neuropathol Exp Neurol 1997 56 1095 1097 10.1097/00005072-199710000-00002 9329452
28. Neuropathological stageing of Alzheimer-related changes. H Braak, E Braak, Acta Neuropathol 1991 82 239 259 10.1007/BF00308809 1759558
29. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. PV Arriagada, JH Growdon, ET Hedley-Whyte, BT Hyman, Neurology 1992 42 631 639 10.1212/WNL.42.3.631 1549228
30. Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study. ME Murray, NR Graff-Radford, OA Ross, RC Petersen, R Duara, DW Dickson, Lancet Neurol 2011 10 785 796 10.1016/S1474-4422(11)70156-9 21802369
31. Focal cortical presentations of Alzheimer's disease. S Alladi, J Xuereb, T Bak, P Nestor, J Knibb, K Patterson, JR Hodges, Brain 2007 130 2636 2645 10.1093/brain/awm213 17898010
32. Atypical and typical presentations of Alzheimer's disease: a clinical, neuropsychological, neuroimaging and pathological study of 13 cases. CJ Galton, K Patterson, JH Xuereb, JR Hodges, Brain 2000 123 484 498 10.1093/brain/123.3. 484 10686172
33. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. GM McKhann, DS Knopman, H Chertkow, BT Hyman, CR Jack Jr, CH Kawas, WE Klunk, WJ Koroshetz, JJ Manly, R Mayeux, RC Mohs, JC Morris, MN Rossor, P Scheltens, MC Carrillo, B Thies, S Weintraub, CH Phelps, Alzheimers Dement 2011 7 263 269 10.1016/j.jalz.2011.03. 005 21514250
34. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. MS Albert, ST DeKosky, D Dickson, B Dubois, HH Feldman, NC Fox, A Gamst, DM Holtzman, WJ Jagust, RC Petersen, PJ Snyder, MC Carrillo, B Thies, CH Phelps, Alzheimers Dement 2011 7 270 279 10.1016/j.jalz.2011.03.008 21514249
35. Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. I Grundke-Iqbal, K Iqbal, M Quinlan, YC Tung, MS Zaidi, HM Wisniewski, J Biol Chem 1986 261 6084 6089 3084478
36. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. I Grundke-Iqbal, K Iqbal, YC Tung, M Quinlan, HM Wisniewski, LI Binder, Proc Natl Acad Sci USA 1986 83 4913 4917 10.1073/pnas.83.13.4913 3088567
37. National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease. BT Hyman, CH Phelps, TG Beach, EH Bigio, NJ Cairns, MC Carrillo, DW Dickson, C Duyckaerts, MP Frosch, E Masliah, SS Mirra, PT Nelson, JA Schneider, DR Thal, B Thies, JQ Trojanowski, HV Vinters, TJ Montine, Alzheimers Dement 2012 8 1 13 10.1016/j.jalz.2011.10.007 22265587
38. Phases of A beta-deposition in the human brain and its relevance for the development of AD. DR Thal, U Rüb, M Orantes, H Braak, Neurology 2002 58 1791 1800 10.1212/WNL.58.12.1791 12084879
39. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. H Braak, I Alafuzoff, T Arzberger, H Kretzschmar, K Del Tredici, Acta Neuropathol 2006 112 389 404 10.1007/s00401-006-0127-z 16906426
40. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. SS Mirra, A Heyman, D McKeel, SM Sumi, BJ Crain, LM Brownlee, FS Vogel, JP Hughes, G van Belle, L Berg, Neurology 1991 41 479 486 10.1212/WNL.41.4.479 2011243
41. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. RA Sperling, PS Aisen, LA Beckett, DA Bennett, S Craft, AM Fagan, T Iwatsubo, CR Jack Jr, J Kaye, TJ Montine, DC Park, EM Reiman, CC Rowe, E Siemers, Y Stern, K Yaffe, MC Carrillo, B Thies, M Morrison-Bogorad, MV Wagster, CH Phelps, Alzheimers Dement 2011 7 280 292 10.1016/j.jalz.2011.03.003 21514248
42. Preliminary NINDS neuropathologic criteria for Steele-Richardson- Olszewski syndrome (progressive supranuclear palsy). JJ Hauw, SE Daniel, D Dickson, DS Horoupian, K Jellinger, PL Lantos, A McKee, M Tabaton, I Litvan, Neurology 1994 44 2015 2019 10.1212/WNL.44.11.2015 7969952
43. Atrophy of superior cerebellar peduncle in progressive supranuclear palsy. Y Tsuboi, J Slowinski, KA Josephs, WG Honer, ZK Wszolek, DW Dickson, Neurology 2003 60 1766 1769 10.1212/01.WNL.0000068011.21396.F4 12796528
44. Voxel-based morphometry in autopsy proven PSP and CBD. KA Josephs, JL Whitwell, DW Dickson, BF Boeve, DS Knopman, RC Petersen, JE Parisi, CR Jack Jr, Neurobiol Aging 2008 29 280 289 10.1016/j.neurobiolaging.2006.09.019 17097770
45. Appearance of paired nucleated, Tau-positive glia in patients with progressive supranuclear palsy brain tissue. T Yamada, PL McGeer, EG McGeer, Neurosci Lett 1992 135 99 102 10.1016/0304-3940(92)90145-W 1371861
46. Progressive supranuclear palsy with dementia: cortical pathology. EH Bigio, DF Brown, CL White 3rd, J Neuropathol Exp Neurol 1999 58 359 364 10.1097/00005072-199904000-00006 10218631
47. Atypical progressive supranuclear palsy underlying progressive apraxia of speech and nonfluent aphasia. KA Josephs, BF Boeve, JR Duffy, GE Smith, DS Knopman, JE Parisi, RC Petersen, DW Dickson, Neurocase 2005 11 283 296 10.1080/13554790590963004 16093229
48. Clinical and neuropathologic features of progressive supranuclear palsy with severe pallido-nigro-luysial degeneration and axonal dystrophy. Z Ahmed, KA Josephs, J Gonzalez, A DelleDonne, DW Dickson, Brain 2008 131 460 472 10.1093/brain/awm301 18158316
49. Pure akinesia with gait freezing: a third clinical phenotype of progressive supranuclear palsy. DR Williams, JL Holton, K Strand, T Revesz, AJ Lees, Mov Disord 2007 22 2235 2241 10.1002/mds.21698 17712855
50. Association of an extended haplotype in the tau gene with progressive supranuclear palsy. M Baker, I Litvan, H Houlden, J Adamson, D Dickson, J Perez-Tur, J Hardy, T Lynch, E Bigio, M Hutton, Hum Mol Genet 1999 8 711 715 10.1093/hmg/8.4.711 10072441
51. Genetic evidence for the involvement of tau in progressive supranuclear palsy. C Conrad, A Andreadis, JQ Trojanowski, DW Dickson, D Kang, X Chen, W Wiederholt, L Hansen, E Masliah, LJ Thal, R Katzman, Y Xia, T Saitoh, Ann Neurol 1997 41 277 281 10.1002/ana.410410222 9029080
52. Identification of a novel polymorphism in the promoter region of the tau gene highly associated to progressive supranuclear palsy in humans. M Ezquerra, P Pastor, F Valldeoriola, JL Molinuevo, R Blesa, E Tolosa, R Oliva, Neurosci Lett 1999 275 183 186 10.1016/S0304-3940(99)00738-7 10580705
53. Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. H Houlden, M Baker, HR Morris, N MacDonald, S Pickering-Brown, J Adamson, AJ Lees, MN Rossor, NP Quinn, A Kertesz, MN Khan, J Hardy, PL Lantos, P St George-Hyslop, DG Munoz, D Mann, AE Lang, C Bergeron, EH Bigio, I Litvan, KP Bhatia, D Dickson, NW Wood, M Hutton, Neurology 2001 56 1702 1706 10.1212/WNL.56.12.1702 11425937
54. Novel haplotypes in 17q21 are associated with progressive supranuclear palsy. P Pastor, M Ezquerra, JC Perez, S Chakraverty, J Norton, BA Racette, D McKeel, JS Perlmutter, E Tolosa, AM Goate, Ann Neurol 2004 56 249 258 10.1002/ana.20178 15293277
55. High-density SNP haplotyping suggests altered regulation of tau gene expression in progressive supranuclear palsy. R Rademakers, S Melquist, M Cruts, J Theuns, J Del-Favero, P Poorkaj, M Baker, K Sleegers, R Crook, T De Pooter, S Bel Kacem, J Adamson, D Van den Bossche, M Van den Broeck, J Gass, E Corsmit, P De Rijk, N Thomas, S Engelborghs, M Heckman, I Litvan, J Crook, PP De Deyn, D Dickson, GD Schellenberg, C Van Broeckhoven, ML Hutton, Hum Mol Genet 2005 14 3281 3292 10.1093/hmg/ddi361 16195395
56. Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy. GU Höglinger, NM Melhem, DW Dickson, PM Sleiman, LS Wang, L Klei, R Rademakers, R de Silva, I Litvan, DE Riley, JC van Swieten, P Heutink, ZK Wszolek, RJ Uitti, J Vandrovcova, HI Hurtig, RG Gross, W Maetzler, S Goldwurm, E Tolosa, B Borroni, P Pastor, LB Cantwell, MR Han, A Dillman, MP van der Brug, JR Gibbs, MR Cookson, DG Hernandez, PSP Genetics Study Group, Nat Genet 2011 43 699 705 10.1038/ng.859 21685912
57. Office of rare diseases neuropathologic criteria for corticobasal degeneration. DW Dickson, C Bergeron, SS Chin, C Duyckaerts, D Horoupian, K Ikeda, K Jellinger, PL Lantos, CF Lippa, SS Mirra, M Tabaton, JP Vonsattel, K Wakabayashi, I Litvan, Office of Rare Diseases of the National Institutes of Health, J Neuropathol Exp Neurol 2002 61 935 946 12430710
58. Widespread cytoskeletal pathology characterizes corticobasal degeneration. MB Feany, DW Dickson, Am J Pathol 1995 146 1388 1396 7778678
59. Astrocytic plaques and tufts of abnormal fibers do not coexist in corticobasal degeneration and progressive supranuclear palsy. T Komori, N Arai, M Oda, H Nakayama, H Mori, S Yagishita, T Takahashi, N Amano, S Murayama, S Murakami, N Shibata, M Kobayashi, S Sasaki, M Iwata, Acta Neuropathol 1998 96 401 408 10.1007/s004010050911 9797005
60. Corticodentatonigral degeneration with neuronal achromasia: a progressive disorder of late adult life. JJ Rebeiz, EH Kolodny, EP Richardson Jr, Trans Am Neurol Assoc 1967 92 23 26 5634049
61. Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration. I Litvan, DA Grimes, AE Lang, J Jankovic, A McKee, M Verny, K Jellinger, KR Chaudhuri, RK Pearce, J Neurol 1999 246 I/1 II/5
62. Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration. DW Dickson, J Neurol 1999 246 I/6 II/15
63. Corticobasal degeneration: a pathologically distinct 4R tauopathy. N Kouri, JL Whitwell, KA Josephs, R Rademakers, DW Dickson, Nat Rev Neurol 2011 7 263 272 10.1038/nrneurol.2011.43 21487420
64. Corticobasal ganglionic degeneration. RL Watts, SS Mirra, Movement Disorders London: Butterworth, Marsden CD, Fahn S, 1994 282 299
65. Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study. I Litvan, Y Agid, C Goetz, J Jankovic, GK Wenning, JP Brandel, EC Lai, M Verny, K Ray-Chaudhuri, A McKee, K Jellinger, RK Pearce, JJ Bartko, Neurology 1997 48 119 125 10.1212/WNL.48.1.119 9008506
66. Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia. BF Boeve, AE Lang, I Litvan, Ann Neurol 2003 54 15 S19 10.1002/ana.10570 12833363
67. Criteria for the diagnosis of corticobasal degeneration. MJ Armstrong, I Litvan, AE Lang, TH Bak, KP Bhatia, B Borroni, AL Boxer, DW Dickson, M Grossman, M Hallett, KA Josephs, A Kertesz, SE Lee, BL Miller, SG Reich, DE Riley, E Tolosa, AI Troster, M Vidailhet, WJ Weiner, Neurology 2013 80 496 503 10.1212/WNL.0b013e31827f0fd1 23359374
68. Cortical-basal ganglionic degeneration. DE Riley, AE Lang, A Lewis, L Resch, P Ashby, O Hornykiewicz, S Black, Neurology 1990 40 1203 1212 10.1212/WNL.40.8.1203 2381527
69. Clinical and pathological features of corticobasal degeneration. WR Gibb, PJ Luthert, CD Marsden, Adv Neurol 1990 53 51 54 2239491
70. Phenotypes and prognosis: clinicopathologic studies of corticobasal degeneration. I Litvan, DA Grimes, AE Lang, Adv Neurol 2000 82 183 196 10624482
71. Cognitive and motor assessment in autopsy-proven corticobasal degeneration. R Murray, M Neumann, MS Forman, J Farmer, L Massimo, A Rice, BL Miller, JK Johnson, CM Clark, HI Hurtig, ML Gorno-Tempini, VM Lee, JQ Trojanowski, M Grossman, Neurology 2007 68 1274 1283 10.1212/01.wnl.0000259519. 78480.c3 17438218
72. Does corticobasal degeneration exist? A clinicopathological re-evaluation. H Ling, SS O'Sullivan, JL Holton, T Revesz, LA Massey, DR Williams, DC Paviour, AJ Lees, Brain 2010 133 2045 2057 10.1093/brain/awq123 20584946
73. Neuropathological features of corticobasal degeneration presenting as corticobasal syndrome or Richardson syndrome. N Kouri, ME Murray, A Hassan, R Rademakers, RJ Uitti, BF Boeve, NR Graff-Radford, ZK Wszolek, I Litvan, KA Josephs, DW Dickson, Brain 2011 134 3264 3275 10.1093/brain/awr234 21933807
74. Corticobasal ganglionic degeneration and progressive supranuclear palsy presenting with cognitive decline. C Bergeron, A Davis, AE Lang, Brain Pathol 1998 8 355 365 9546292
75. Dementia as the most common presentation of cortical-basal ganglionic degeneration. DA Grimes, AE Lang, CB Bergeron, Neurology 1999 53 1969 1974 10.1212/WNL.53.9.1969 10599767
76. Clinicopathological correlations in corticobasal degeneration. SE Lee, GD Rabinovici, MC Mayo, SM Wilson, WW Seeley, SJ DeArmond, EJ Huang, JQ Trojanowski, ME Growdon, JY Jang, M Sidhu, TM See, AM Karydas, ML Gorno-Tempini, AL Boxer, MW Weiner, MD Geschwind, KP Rankin, BL Miller, Ann Neurol 2011 70 327 340 10.1002/ana.22424 21823158
77. The corticobasal degeneration syndrome overlaps progressive aphasia and frontotemporal dementia. A Kertesz, P Martinez-Lage, W Davidson, DG Munoz, Neurology 2000 55 1368 1375 10.1212/WNL.55.9.1368 11087783
78. Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP. KA Josephs, RC Petersen, DS Knopman, BF Boeve, JL Whitwell, JR Duffy, JE Parisi, DW Dickson, Neurology 2006 66 41 48 10.1212/01.wnl.0000191307.69661.c3 16401843
79. Symmetric corticobasal degeneration (S-CBD). A Hassan, JL Whitwell, BF Boeve, CR Jack Jr, JE Parisi, DW Dickson, KA Josephs, Parkinsonism Relat Disord 2010 16 208 214 10.1016/j.parkreldis.2009.11.013 20018548
80. Neuropathology of the hippocampus in FTLD-Tau with Pick bodies: a study of the BrainNet Europe Consortium. GG Kovacs, AJ Rozemuller, JC van Swieten, E Gelpi, K Majtenyi, S Al-Sarraj, C Troakes, I Bódi, A King, T Hortobágyi, MM Esiri, O Ansorge, G Giaccone, I Ferrer, T Arzberger, N Bogdanovic, T Nilsson, I Leisser, I Alafuzoff, JW Ironside, H Kretzschmar, H Budka, Neuropathol Appl Neurobiol 2013 39 166 178 10.1111/j.1365-2990.2012. 01272.x
81. Progressive aphasia in a patient with Pick's disease: a neuropsychological, radiologic, and anatomic study. NR Graff-Radford, AR Damasio, BT Hyman, MN Hart, D Tranel, H Damasio, GW Van Hoesen, K Rezai, Neurology 1990 40 620 626 10.1212/WNL.40.4.620 2320235
82. Nonfluent/agrammatic PPA with in-vivo cortical amyloidosis and Pick's disease pathology. F Caso, B Gesierich, M Henry, M Sidhu, A LaMarre, M Babiak, BL Miller, GD Rabinovici, EJ Huang, G Magnani, M Filippi, G Comi, WW Seeley, ML Gorno-Tempini, Behav Neurol 2013 26 95 106 22713404
83. Pathological heterogeneity of the precentral gyrus in Pick's disease: a study of 16 autopsy cases. K Tsuchiya, YS Piao, T Oda, A Mochizuki, K Arima, K Hasegawa, C Haga, A Kakita, K Hori, I Tominaga, S Yagishita, H Akiyama, H Takahashi, Acta Neuropathol 2006 112 29 42 10.1007/s00401-005-0028-6 16609852
84. Parietal Picks-disease mimicking cortical-basal ganglionic degeneration. AE Lang, C Bergeron, MS Pollanen, P Ashby, Neurology 1994 44 1436 1440 10.1212/WNL.44.8.1436 8058145
85. Primary progressive apraxia in Pick's disease: a clinicopathologic study. T Fukui, K Sugita, M Kawamura, J Shiota, I Nakano, Neurology 1996 47 467 473 10.1212/WNL.47.2.467 8757022
86. Hereditary Pick's disease with the G272V tau mutation shows predominant three-repeat tau pathology. IF Bronner, BC ter Meulen, A Azmani, LA Severijnen, R Willemsen, W Kamphorst, R Ravid, P Heutink, JC van Swieten, Brain 2005 128 2645 2653 10.1093/brain/awh591 16014652
87. Tau gene mutation G389R causes a tauopathy with abundant pick body-like inclusions and axonal deposits. JR Murrell, MG Spillantini, P Zolo, M Guazzelli, MJ Smith, M Hasegawa, F Redi, RA Crowther, P Pietrini, B Ghetti, M Goedert, J Neuropathol Exp Neurol 1999 58 1207 1226 10.1097/00005072-199912000-00002 10604746
88. Pick's disease is associated with mutations in the tau gene. S Pickering-Brown, M Baker, SH Yen, WK Liu, M Hasegawa, N Cairns, PL Lantos, M Rossor, T Iwatsubo, Y Davies, D Allsop, R Furlong, F Owen, J Hardy, D Mann, M Hutton, Ann Neurol 2000 48 859 867 10.1002/1531-8249(200012)48:6<859::AID- ANA6>3.0.CO;2-1 11117542
89. Pick's disease: hyperphosphorylated tau protein segregates to the somatoaxonal compartment. A Probst, M Tolnay, D Langui, M Goedert, MG Spillantini, Acta Neuropathol 1996 92 588 596 10.1007/s004010050565 8960316
90. An immunohistochemical study of cases of sporadic and inherited frontotemporal lobar degeneration using 3R- and 4R-specific tau monoclonal antibodies. R de Silva, T Lashley, C Strand, AM Shiarli, J Shi, J Tian, KL Bailey, P Davies, EH Bigio, K Arima, E Iseki, S Murayama, H Kretzschmar, M Neumann, C Lippa, G Halliday, J MacKenzie, R Ravid, D Dickson, Z Wszolek, T Iwatsubo, SM Pickering-Brown, J Holton, A Lees, T Revesz, DM Mann, Acta Neuropathol 2006 111 329 340 10.1007/s00401-006-0048-x 16552612
91. Neuropathology of Pick's disease. DW Dickson, Neurology 2001 56 16 S20 10.1212/WNL.56.suppl-4.S16 11402145
92. Relationships between radiotracer properties and image quality in molecular imaging of the brain with positron emission tomography. M Laruelle, M Slifstein, Y Huang, Mol Imaging Biol 2003 5 363 375 10.1016/j.mibio.2003.09.009 14667491
93. Research towards tau imaging. JR Jensen, K Cisek, KE Funk, S Naphade, KN Schafer, J Kuret, J Alzheimers Dis 2011 26 147 157 21971459
94. Binding characteristics of radiofluorinated 6-dialkylamino-2- naphthylethylidene derivatives as positron emission tomography imaging probes for beta-amyloid plaques in Alzheimer's disease. ED Agdeppa, V Kepe, J Liu, S Flores-Torres, N Satyamurthy, A Petric, GM Cole, GW Small, SC Huang, JR Barrio, J Neurosci 2001 21 C189 11734604
95. Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease. K Shoghi-Jadid, GW Small, ED Agdeppa, V Kepe, LM Ercoli, P Siddarth, S Read, N Satyamurthy, A Petric, SC Huang, JR Barrio, Am J Geriatr Psychiatry 2002 10 24 35 11790632
96. Molecular-imaging probe 2-(1-[6-[(2-fluoroethyl)(methyl) amino]-2-naphthyl]ethylidene) malononitrile labels prion plaques in vitro. M Bresjanac, LM Smid, TD Vovko, A Petric, JR Barrio, M Popovic, J Neurosci 2003 23 8029 8033 12954864
97. The 2,6-disubstituted naphthalene derivative FDDNP labeling reliably predicts Congo red birefringence of protein deposits in brain sections of selected human neurodegenerative diseases. LM Smid, TD Vovko, M Popovic, A Petric, V Kepe, JR Barrio, G Vidmar, M Bresjanac, Brain Pathol 2006 16 124 130 10.1111/j.1750-3639.2006.00006.x 16768752
98. PET imaging of neuropathology in tauopathies: progressive supranuclear palsy. V Kepe, Y Bordelon, A Boxer, SC Huang, J Liu, FC Thiede, JC Mazziotta, MF Mendez, N Donoghue, GW Small, JR Barrio, J Alzheimers Dis 2013 36 145 153 23579330
99. Quinoline and benzimidazole derivatives: candidate probes for in vivo imaging of tau pathology in Alzheimer's disease. N Okamura, T Suemoto, S Furumoto, M Suzuki, H Shimadzu, H Akatsu, T Yamamoto, H Fujiwara, M Nemoto, M Maruyama, H Arai, K Yanai, T Sawada, Y Kudo, J Neurosci 2005 25 10857 10862 10.1523/JNEUROSCI.1738-05.2005 16306398
100. 18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease. MT Fodero-Tavoletti, N Okamura, S Furumoto, RS Mulligan, AR Connor, CA McLean, D Cao, A Rigopoulos, GA Cartwright, G O'Keefe, S Gong, PA Adlard, KJ Barnham, CC Rowe, CL Masters, Y Kudo, R Cappai, K Yanai, VL Villemagne, Brain 2011 134 1089 1100 10.1093/brain/awr038 21436112
101. Comparison of the binding characteristics of [18F]THK-523 and other amyloid imaging tracers to Alzheimer's disease pathology. R Harada, N Okamura, S Furumoto, T Tago, M Maruyama, M Higuchi, T Yoshikawa, H Arai, R Iwata, Y Kudo, K Yanai, Eur J Nucl Med Mol Imaging 2013 40 125 132 10.1007/s00259-012-2261-2 23100049
102. In vivo tau imaging in Alzheimer's disease. V Villemagne, S Furumoto, M Fodero-Tavoletti, R Mulligan, J Hodges, Y Kudo, C Masters, K Yanai, C Rowe, N Okamura, J Nucl Med Meeting Abstracts 2012 53 36
103. A highly selective and specific PET tracer for imaging of tau pathologies. W Zhang, J Arteaga, DK Cashion, G Chen, U Gangadharmath, LF Gomez, D Kasi, C Lam, Q Liang, C Liu, VP Mocharla, F Mu, A Sinha, AK Szardenings, E Wang, JC Walsh, C Xia, C Yu, T Zhao, HC Kolb, J Alzheimers Dis 2012 31 601 612 22683529
104. Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807. DT Chien, AK Szardenings, S Bahri, JC Walsh, F Mu, C Xia, WR Shankle, AJ Lerner, MY Su, A Elizarov, HC Kolb, J Alzheimers Dis 2013 34 457 468 23234879
105. [(18)F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease. CF Xia, J Arteaga, G Chen, U Gangadharmath, LF Gomez, D Kasi, C Lam, Q Liang, C Liu, VP Mocharla, F Mu, A Sinha, H Su, AK Szardenings, JC Walsh, E Wang, C Yu, W Zhang, T Zhao, HC Kolb, Alzheimers Dement 2013 [Epub ahead of print]
106. Neurofibrillary tangles in progressive supranuclear palsy contain the same tau epitopes identified in Alzheimer's disease PHFtau. ML Schmidt, R Huang, JA Martin, J Henley, M Mawal-Dewan, HI Hurtig, VM Lee, JQ Trojanowski, J Neuropathol Exp Neurol 1996 55 534 539 10.1097/00005072-199605000-00006 8627344
107. Corticobasal degeneration: a disease with widespread appearance of abnormal tau and neurofibrillary tangles, and its relation to progressive supranuclear palsy. H Mori, M Nishimura, Y Namba, M Oda, Acta Neuropathol 1994 88 113 121 10.1007/BF00294503 7985491
108. Filaments of Pick's bodies contain altered cytoskeletal elements. G Perry, D Stewart, R Friedman, V Manetto, L Autilio-Gambetti, P Gambetti, Am J Pathol 1987 127 559 568 3296772
109. The challenges of tau imaging. VL Villemagne, S Furumoto, MT Fodero-Tavoletti, R Harada, RS Mulligan, Y Kudo, CL Masters, K Yanai, CC Rowe, N Okamura, Future Neurol 2012 7 409 421 10.2217/fnl.12.34
110. Characterization of PiB binding to white matter in Alzheimer disease and other dementias. MT Fodero-Tavoletti, CC Rowe, CA McLean, L Leone, QX Li, CL Masters, R Cappai, VL Villemagne, J Nucl Med 2009 50 198 204 10.2967/jnumed.108.057984 19164220
111. Levels of normal and abnormally phosphorylated tau in different cellular and regional compartments of Alzheimer disease and control brains. S Khatoon, I Grundke-Iqbal, K Iqbal, FEBS Lett 1994 351 80 84 10.1016/0014-5793(94)00829-9 8076698
112. The distribution of tau in the mammalian central nervous system. LI Binder, A Frankfurter, LI Rebhun, J Cell Biol 1985 101 1371 1378 10.1083/jcb.101.4.1371 3930508
113. The histological validation of post mortem magnetic resonance imaging-determined hippocampal volume in Alzheimer's disease. M Bobinski, MJ de Leon, J Wegiel, S Desanti, A Convit, LA Saint Louis, H Rusinek, HM Wisniewski, Neuroscience 2000 95 721 725 10670438
114. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. T Gómez-Isla, R Hollister, H West, S Mui, JH Growdon, RC Petersen, JE Parisi, BT Hyman, Ann Neurol 1997 41 17 24 10.1002/ana.410410106 9005861
115. Hippocampal volume as an index of Alzheimer neuropathology: findings from the Nun Study. KM Gosche, JA Mortimer, CD Smith, WR Markesbery, DA Snowdon, Neurology 2002 58 1476 1482 10.1212/WNL.58.10.1476 12034782
116. Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia. CR Jack Jr, DW Dickson, JE Parisi, YC Xu, RH Cha, PC O'Brien, SD Edland, GE Smith, BF Boeve, EG Tangalos, E Kokmen, RC Petersen, Neurology 2002 58 750 757 10.1212/WNL.58.5.750 11889239
117. Changes in premorbid brain volume predict Alzheimer's disease pathology. LC Silbert, JF Quinn, MM Moore, E Corbridge, MJ Ball, G Murdoch, G Sexton, JA Kaye, Neurology 2003 61 487 492 10.1212/01.WNL.0000079053.77227.14 12939422
118. White matter imaging helps dissociate tau from TDP-43 in frontotemporal lobar degeneration. CT McMillan, DJ Irwin, BB Avants, J Powers, PA Cook, JB
119. Correlation of Alzheimer-like tau hyperphosphorylation and fMRI bold intensity. W Xiao-Chuan, H Zheng-Hui, F Zheng-Yu, F Yue, Y Yun-Huang, W Qun, T Xiao-Wei, W Yi-Gen, W Jian-Zhi, Curr Alzheimer Res 2004 1 143 148 10.2174/1567205043332216 15975079
120. Metabolic mapping of functional activity in the hypothalamo- neurohypophysial system of the rat. WJ Schwartz, CB Smith, L Davidsen, H Savaki, L Sokoloff, M Mata, DJ Fink, H Gainer, Science 1979 205 723 725 10.1126/science.462184 462184
121. An energy budget for signaling in the grey matter of the brain. D Attwell, SB Laughlin, J Cereb Blood Flow Metab 2001 21 1133 1145 11598490
122. Resting-state brain glucose utilization as measured by PET is directly related to regional synaptophysin levels: a study in baboons. AB Rocher, F Chapon, X Blaizot, JC Baron, C Chavoix, Neuroimage 2003 20 1894 1898 10.1016/j.neuroimage.2003.07.002 14642499
123. Atrophy of medial temporal lobes on MRI in 'probable' Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. P Scheltens, D Leys, F Barkhof, D Huglo, HC Weinstein, P Vermersch, M Kuiper, M Steinling, EC Wolters, J Valk, J Neurol Neurosurg Psychiatry 1992 55 967 972 10.1136/jnnp.55.10.967 1431963
124. MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease. CR Jack Jr, RC Petersen, PC O'Brien, EG Tangalos, Neurology 1992 42 183 188 10.1212/WNL.42.1.183 1734300
125. MRI correlates of neurofibrillary tangle pathology at autopsy: a voxel-based morphometry study. JL Whitwell, KA Josephs, ME Murray, K Kantarci, SA Przybelski, SD Weigand, P Vemuri, ML Senjem, JE Parisi, DS Knopman, BF Boeve, RC Petersen, DW Dickson, CR Jack Jr, Neurology 2008 71 743 749 10.1212/01.wnl.0000324924.91351.7d 18765650
126. Functional imaging predicts cognitive decline in Alzheimer's disease. WJ Jagust, MN Haan, JL Eberling, N Wolfe, BR Reed, J Neuroimaging 1996 6 156 160 8704290
127. Abnormal metabolic networks in atypical parkinsonism. T Eckert, C Tang, Y Ma, N Brown, T Lin, S Frucht, A Feigin, D Eidelberg, Mov Disord 2008 23 727 733 10.1002/mds.21933 18186116
128. Study of the rostral midbrain atrophy in progressive supranuclear palsy. N Kato, K Arai, T Hattori, J Neurol Sci 2003 210 57 60 10.1016/S0022-510X(03) 00014-5 12736089
129. Quantitative MRI measurement of superior cerebellar peduncle in progressive supranuclear palsy. DC Paviour, SL Price, JM Stevens, AJ Lees, NC Fox, Neurology 2005 64 675 679 10.1212/01.WNL.0000151854.85743.C7 15728291
130. Voxel-based comparison of regional cerebral glucose metabolism between PSP and corticobasal degeneration. K Hosaka, K Ishii, S Sakamoto, T Mori, M Sasaki, N Hirono, E Mori, J Neurol Sci 2002 199 67 71 10.1016/S0022-510X(02) 00102-8 12084445
131. Rates of cerebral atrophy in autopsy-confirmed progressive supranuclear palsy. KA Josephs, JL Whitwell, BF Boeve, MM Shiung, JL Gunter, JE Parisi, DW Dickson, CR Jack, Ann Neurol 2006 59 200 203 10.1002/ana.20707 16278856
132. Rates of cerebral atrophy differ in different degenerative pathologies. JL Whitwell, CR Jack Jr, JE Parisi, DS Knopman, BF Boeve, RC Petersen, TJ Ferman, DW Dickson, KA Josephs, Brain 2007 130 1148 1158 17347250
133. Cerebral glucose metabolism in patients with frontotemporal dementia. K Ishii, S Sakamoto, M Sasaki, H Kitagaki, S Yamaji, M Hashimoto, T Imamura, T Shimomura, N Hirono, E Mori, J Nucl Med 1998 39 1875 1878 9829574
134. Neuroimaging in frontotemporal lobar degeneration-predicting molecular pathology. JL Whitwell, KA Josephs, Nat Rev Neurol 2011 8 131 142
135. Atrophy patterns in histologic vs clinical groupings of frontotemporal lobar degeneration. JM Pereira, GB Williams, J Acosta-Cabronero, G Pengas, MG Spillantini, JH Xuereb, JR Hodges, PJ Nestor, Neurology 2009 72 1653 1660 10.1212/WNL.0b013e3181a55fa2 19433738
136. Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration. JD Rohrer, T Lashley, JM Schott, JE Warren, S Mead, AM Isaacs, J Beck, J Hardy, R de Silva, E Warrington, C Troakes, S Al-Sarraj, A King, B Borroni, MJ Clarkson, S Ourselin, JL Holton, NC Fox, T Revesz, MN Rossor, JD Warren, Brain 2011 134 2565 2581 10.1093/brain/awr198 21908872
137. Distinct profiles of brain atrophy in frontotemporal lobar degeneration caused by progranulin and tau mutations. JD Rohrer, GR Ridgway, M Modat, S Ourselin, S Mead, NC Fox, MN Rossor, JD Warren, Neuroimage 2010 53 1070 1076 10.1016/j.neuroimage.2009.12.088 20045477